Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2021;11(4): 739-745. doi: 10.34172/apb.2021.083
PMID: 34888221        PMCID: PMC8642797

Research Article

Assessment of the Effect of Infliximab on Immunomodulation Properties of Mesenchymal Stem Cells In Vitro

Yasaman Aliasghari Sakha 1 ORCID, Ehsan Ehsani 2 * ORCID, Elham Roshandel 3, Arsalan Jalili 3,4, Negar Vahdani 3, Abbas Hajifathali 3 * ORCID

Cited by CrossRef: 6

1- Wang L, Cheng F. Comments on: “Long-term efficacy of mesenchymal stem cell treatment for complex perianal fistulas: A systematic review and meta-analysis”. Cent Eur J Immunol. 2025;(1):11 [Crossref]
2- Zheng J, Wang H, Ge L. Advances in Exosome Research: Multifaceted Roles in Myeloid Leukemia Progression and Therapy. J Biochem & Molecular Tox. 2025;39(6) [Crossref]
3- Zoehler B, Fracaro L, Boldrini-Leite L, da Silva J, Travers P, Brofman P, Bicalho M, Senegaglia A. HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy. Cells. 2022;11(8):1339 [Crossref]
4- Cheng F. Comments on: �Perianal Crohn�s disease: clinical implications, prognosis and use of resources�. Rev Esp Enferm Dig. 2023; [Crossref]
5- Cheng F. Comment on “A phase IB/IIA study of ex vivo expanded allogeneic bone-marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn disease.”. Surgery. 2024;175(5):1463 [Crossref]
6- Riss S, Dawoud C. Reply to comments on: “Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease—A prospective nationwide multicenter cohort study”. Wien Klin Wochenschr. 2024;136(9-10):297 [Crossref]
7- Dimova A, Erceg Ivkošić I, Brlek P, Dimov S, Pavlović T, Bokun T, Primorac D. Novel Approach in Rectovaginal Fistula Treatment: Combination of Modified Martius Flap and Autologous Micro-Fragmented Adipose Tissue. Biomedicines. 2023;11(9):2509 [Crossref]
8- Lethager L, Bangsgaard S, Mønsted Johansen E, Ali Qayyum A, Pravsgaard Christensen J, Ekblond A, Juhl Nørgaard M, Drozd Højgaard L. In vitro assays for investigating the immunomodulatory properties of human mesenchymal stromal cells. Stem Cell Res Ther. 2026; [Crossref]
9- Ye M, Cheng F. Comments on: “Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease—A prospective nationwide multicenter cohort study”. Wien Klin Wochenschr. 2024;136(9-10):295 [Crossref]